TransMedics Group, Inc. (NASDAQ:TMDX) About To Shift From Loss To Profit [Yahoo! Finance]
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The US$4.6b market-cap company posted a loss in its most recent financial year of US$25m and a latest trailing-twelve-month loss of US$10m shrinking the gap between loss and breakeven. The most pressing concern for investors is TransMedics Group's path to profitability – when will it breakeven? In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable. View our latest analysis for TransMedics Group Consensus from 9 of the American Medical Equipment analysts is that TransMedics Group is on the verge of breakeven. They anticipate the company to incur a final loss in 2023, before generating positive profits of US$34m in 2024. Therefore, the company is expected to breakeven roughly 12 months from now or less. At what rate
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $120.00 price target on the stock.MarketBeat
- TransMedics (TMDX) Just Reclaimed the 20-Day Moving Average [Yahoo! Finance]Yahoo! Finance
- TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at TD Cowen from $130.00 to $175.00. They now have a "buy" rating on the stock.MarketBeat
- TransMedics Group, Inc. (NASDAQ: TMDX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $161.00 price target on the stock.MarketBeat
TMDX
Earnings
- 4/30/24 - Beat
TMDX
Sec Filings
- 6/17/24 - Form 4
- 6/7/24 - Form 4
- 6/5/24 - Form 144
- TMDX's page on the SEC website